Roger Nosal
Senior Vice President & Head, Regulatory Affairs & Quality Assurance, Vaxcyte
Roger Nosal is the Senior Vice President & Head of Regulatory Affairs and Quality Assurance for Vaxcyte, Inc. In this role he is accountable for executing the development and prosecution of global regulatory and quality assurance strategies to deliver Vaxcyte vaccine product assets. He is also currently serving as an independent Principal Consultant for Roger Nosal PharmaCMC Regulatory Consultants, LLC supporting The Blackstone Group. In this role he provides due diligence assessments and estimates of probability of success for companies and assets from which investment decisions can be made.